期刊文献+

ErbB2基因rs1058808位点多态性与延边地区HBV相关肝细胞肝癌的关系及民族差异 被引量:5

Relationship of ErbB2 gene rs1058808 polymorphism with HBV-related hepatocellular carcinoma in Yanbian area and ethnic difference
暂未订购
导出
摘要 目的观察延边地区乙型肝炎病毒(HBV)相关肝细胞肝癌(HCC)患者ErbB2基因rs1058808位点多态性,探讨rs1058808位点多态性与HBV相关HCC的关系及民族差异。方法选取66例(朝鲜族28例、汉族38例)HBV相关HCC患者(病例组)和150例(朝鲜族68例、汉族82例)单纯HBV携带者(对照组),采用双脱氧链末端终止法检测ErbB2基因rs1058808位点多态性,并分析两组及不同民族基因型和等位基因的分布情况。结果病例组ErbB2基因rs1058808位点的CC、CG和GG基因型所占比例分别为15.2%、46.9%、37.9%,对照组分别为14.7%、62.7%、22.7%,观察组GG基因型所占比例高于对照组(P<0.01)。病例组朝鲜族和汉族人群ErbB2基因rs1058808位点GG基因型所占比例分别为35.7%、36.8%,均高于对照的23.5%、22.0%(P均<0.01);两组同民族CC、CG基因型及C、G等位基因分布差异无统计学意义,病例组汉族和朝鲜族人群CC、CG和GG基因型及C、G等位基因分布差异无统计学意义(P均>0.05)。结论 ErbB2基因rs1058808位点GG基因型可能是延边地区人群HBV相关HCC发生的主要遗传易感因素,且汉族和朝鲜族间不存在民族差异。 Objective To investigate the rs1058808 polymorphism of ErbB2 gene in hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) in Yanbian area, and to explore the correlation between rs1058806 polymorphism and HBV-related HCC and ethnic differences. Methods The gene polymorphisms of rs1058808 in ErbB2 of 66 cases of patients with HBV associated HCC (the experimental group, including 28 cases of Korean nationality and 38 cases of Han nationality) and 150 cases of pure HBV carriers (the control group, including 68 cases of Korean nationality and 82 cases of Han nationality) were detected by dideoxy chain-termination method. We analyzed the genotype and allele distribution in the two groups. Results Both the two groups had rs1058808 ErbB2 gene loci of CC, CG and GG genotypes, and G gene was the most allele. The proportions of CC, CG and GG genotypes of ErbB2 gene rs1058808 loci in the experimental group were 15.2%, 46.9% and 15.2%, while in the control group they were 14.7%, 62. 7% and 22. 7% ; the proportion of GG genotype in the experimental group was higher than that of the control group (P 〈0. 01 ). The proportions of rs1058808 ErbB2 gene loci GG genotype in the Korean nationality and Han nationality of the experimental group were 35.7%, 36.8%, which were higher than those of the control group (23.5%, 22.0% ) ( all P 〈0.01 ). There was no statistically significant difference between the two national groups in CC, CG genotypes, C and G allele distribution. In the experimental group, there was no statistically significant difference in CC, CG and GG genotypes and C and G allele distribution between Han and Korean patients ( all P 〉0.05). Conclusion The GG genotype of rs1058808 in ErbB2 may be the main genetic risk factor for HBV-associated HCC in Yanbian area, and there is no national differences between Han and Chinese-Korean patients.
作者 崔文豪 李成浩 朴熙绪 许东元 刘兰 CUI Wenhao LI Chenghao PIAO Xixu XU Dongyuan LIU Lan(Yanbian University Hospital, Yanji 133000, China)
出处 《山东医药》 CAS 北大核心 2017年第10期5-7,共3页 Shandong Medical Journal
基金 国家自然科学基金资助项目(81560400) 吉林省教育厅"十二五"科学技术研究项目(2013-13)
关键词 肝细胞肝癌 ERBB2 基因多态性 乙型肝炎病毒 民族差异 延边 hepatocellular carcinoma ErbB2 gene polymorphism hepatitis B virus ethnic difference Yanbian area
  • 相关文献

参考文献4

二级参考文献19

  • 1赵荫农,曹骥,吴飞翔,欧超,袁卫平,莫钦国,韦薇,李瑗,苏建家,梁安民.EGF mRNA和EGFR mRNA在肝细胞癌组织中的表达及其意义[J].癌症,2004,23(7):762-766. 被引量:11
  • 2王文奇,徐瀚峰,刘倩.表皮生长因子及其受体与肝癌的关系[J].国外医学(肿瘤学分册),2005,32(3):212-214. 被引量:12
  • 3方燕,卓子兰,李国辉.20例原发性肝癌实体瘤的细胞遗传学研究[J].中国优生与遗传杂志,1996,4(1):34-37. 被引量:6
  • 4Heinze T, Jonas S, Karsten A, et al. Determination of the oncoganes p53 and C-erbB-2 in the tumour cytosols of advanced hepatocellulax carcinoma(HCC) and correlation to survival time[J]. Anticancer Res, 1999,19(4A) : 2501-2503.
  • 5Rosen PP, Lesser ML, Arroyo CD, et al. Immunohistochemical detection of HER-2/neu in patients with alary lymph node negative breast carcinoma. A study of epidemiological risk factors, histologic features,and prognosis[J]. Cancer, 1995, 75:1320-1326.
  • 6Stahl P, Kissau L, Bamard JA, et al. Total synthesis and biological evaluation of the nakijiquinones[ J ]. Am Chem Soc, 2001, 28 : 11586-11593.
  • 7Wang SC, Hung MC. Her-2 overexpression and cancer targeting[J].Semin Oncol, 2001, 28(5 supple 16) : 115-124.
  • 8Mark DP, Dennis JS. Combination therapy with trastuzumab (Herceptin) and cisplatin for chemoresistant metactaic breast cancer: evidence for reeeptor-enhanced chewnosensitivity[J]. Semin Oncol, 1999,26(4 supple 12) :89-90.
  • 9Press MF, Cordon-Cardo C, Slamor DJ. Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues[J]. Oncogene,1990, 5(7) : 953-962.
  • 10朱世能.肝胆肿瘤[A].见:刘复生主编.肿瘤病理学:第1版[C].北京:北京医科大学中国协和医科大学联合出版社,1997.925-926.

共引文献24

同被引文献46

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部